You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Review: 1-year risk of previously undiagnosed cancer is 6.3% in patients with newly diagnosed venous thromboembolism

https://doi.org/10.1136/ebm.14.2.57

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    M A Rodger

    Dr M A Rodger, Ottawa Health Research Institute, Ottawa, Ontario, Canada; mrodger@ohri.ca

    QUESTION

    In patients with newly diagnosed venous thromboembolism (VTE), what is the risk of previously undiagnosed cancer being detected in the next year?

    REVIEW SCOPE

    Included studies reported the incidence of newly diagnosed cancers in adults with newly diagnosed VTE. Outcomes were the detection of a previously undiagnosed cancer within 1 and 12 months after the diagnosis of VTE.*

    REVIEW METHODS

    Medline and EMBASE/Excerpta Medica (to Nov 2007); Cochrane Register of Controlled Trials and Evidence-Based Medicine Reviews (Issue 4, 2007); journals; conference proceedings; and references were searched for cohort studies or randomised controlled trials. 34 studies (n = 9516) met the selection criteria. 3286 patients had unprovoked (or idiopathic) VTE, 3297 had provoked (or secondary) VTE, and 2933 had unspecified VTE.

    MAIN RESULTS

    The table …

    View Full Text

    Footnotes

    • Source of funding: not stated.